Through awards amounting to approximately $577 million, the National Institute of Allergy and Infectious Diseases (NIAID) is working to create…
A global, Phase 3 trial of approximately 20,000 older adult volunteers for the Bavarian Nordic A/S MVA-BN RSV vaccine candidate…
The Director of National Intelligence (DNI) research and development arm, the Intelligence Advanced Research Projects Activity (IARPA), has initiated the…
U.S. Sens. John Hickenlooper (D-CO) and Bill Cassidy (R-LA) introduced legislation Thursday that would modernize programs currently focused on surveilling…
Nuclear Threat Initiative (NTI) and Munich Security Conference (MSC) personnel are espousing the benefits of a recently convened tabletop exercise…
In support of the federal Project BioShield incentivization effort, the Biomedical Advanced Research and Development Authority (BARDA) recently launched a…
A new partnership between governmental, military, and academic scientists seeks to collaboratively develop a vaccine over the next five years…
BARDA’s Division of Research, Innovation, and Ventures (DRIVe) announced a new Area of Interest (AOI) and that it is looking…
The Bipartisan Commission on Biodefense announced launched a public awareness campaign Wednesday to support the Apollo Program for Biodefense, a…
The Centers for Disease Control and Prevention (CDC) announced Tuesday that it has awarded $22 million to nearly 30 organizations…
This website uses cookies.